• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血栓负荷 ST 段抬高型心肌梗死患者的预扩张球囊:急诊经皮冠状动脉血运重建术患者血流缓慢/无复流的独立预测因素。

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization.

机构信息

National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

National Institute of Cardiovascular Diseases (NICVD), Hyderabad, Pakistan.

出版信息

J Interv Cardiol. 2023 Jan 6;2023:4012361. doi: 10.1155/2023/4012361. eCollection 2023.

DOI:10.1155/2023/4012361
PMID:36712997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9839408/
Abstract

BACKGROUND

Distal embolization due to microthrombus fragments formed during predilation ballooning is considered one of the possible mechanisms of slow flow/no-reflow (SF/NR). Therefore, this study aimed to compare the incidence of intraprocedure SF/NR during the primary percutaneous coronary intervention (PCI) in patients with high thrombus burden (≥4 grade) with and without predilation ballooning for culprit lesion preparation. . This prospective descriptive cross-sectional study included patients with a high thrombus burden (≥4 grades) who underwent primary PCI. Propensity-matched cohorts of patients with and without predilation ballooning in a 1 : 1 ratio were compared for the incidence of intraprocedure SF/NR.

RESULTS

A total of 765 patients with high thrombus burden undergoing primary PCI were included in this study. The mean age was 55.75 ± 11.54 years, and 78.6% (601) were males. Predilation ballooning was conducted in 346 (45.2%) patients. The incidence of intraprocedure SF/NR was significantly higher (41.3% vs. 27.4%; < 0.001) in patients with predilation ballooning than in those without preballooning, respectively. The incidence of intraprocedure SF/NR also remained significantly higher for the predilation ballooning cohort with an incidence rate of 41.3% as against 30.1% (=0.002) for the propensity-matched cohort of patients without predilation ballooning with a relative risk of 1.64 (95% CI: 1.20 to 2.24). Moreover, the in-hospital mortality rate remained higher but insignificant, among patients with and without predilation ballooning (8.1% vs. 4.9%; =0.090).

CONCLUSION

In conclusion, predilation ballooning can be associated with an increased risk of incidence of intraprocedure SF/NR during primary PCI in patients with high thrombus burden.

摘要

背景

在预扩张球囊扩张过程中形成的微血栓碎片导致的远端栓塞被认为是慢血流/无复流(SF/NR)的可能机制之一。因此,本研究旨在比较高血栓负荷(≥4 级)患者在罪犯病变准备中进行预扩张球囊扩张与不进行预扩张球囊扩张时,在初次经皮冠状动脉介入治疗(PCI)过程中 SF/NR 的发生率。

方法

本前瞻性描述性病例对照研究纳入了高血栓负荷(≥4 级)接受初次 PCI 的患者。将高血栓负荷(≥4 级)患者按 1:1 比例进行倾向匹配,比较预扩张球囊组和无预扩张球囊组 SF/NR 的发生率。

结果

本研究共纳入 765 例高血栓负荷接受初次 PCI 的患者。患者的平均年龄为 55.75±11.54 岁,78.6%(601 例)为男性。346 例(45.2%)患者进行了预扩张球囊。与无预扩张球囊组相比,进行预扩张球囊的患者 SF/NR 的发生率显著更高(41.3% vs. 27.4%;<0.001)。预扩张球囊组 SF/NR 的发生率也显著高于倾向匹配的无预扩张球囊组,分别为 41.3%和 30.1%(=0.002),相对风险为 1.64(95%CI:1.20 至 2.24)。此外,有和没有预扩张球囊的患者住院死亡率仍然较高,但无统计学意义(8.1% vs. 4.9%;=0.090)。

结论

总之,在高血栓负荷患者中,预扩张球囊可能与初次 PCI 过程中 SF/NR 发生率增加相关。

相似文献

1
Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization.高血栓负荷 ST 段抬高型心肌梗死患者的预扩张球囊:急诊经皮冠状动脉血运重建术患者血流缓慢/无复流的独立预测因素。
J Interv Cardiol. 2023 Jan 6;2023:4012361. doi: 10.1155/2023/4012361. eCollection 2023.
2
Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.在接受直接经皮冠状动脉血运重建术的 ST 段抬高型心肌梗死患者中,血栓负荷的定量分析作为术中无复流的独立预测因子。
J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):288-294. doi: 10.55519/JAMC-02-9698.
3
Development and Validation of a Novel Risk Stratification Model for Slow-Flow/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF/NR Score).一种新型的原发性经皮冠状动脉介入治疗(RK-SF/NR 评分)中慢血流/无复流风险分层模型的建立与验证。
Am J Cardiol. 2022 May 15;171:32-39. doi: 10.1016/j.amjcard.2022.01.044. Epub 2022 Mar 16.
4
Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死无复流现象的预测因素。
Ann Cardiol Angeiol (Paris). 2021 Jun;70(3):136-142. doi: 10.1016/j.ancard.2021.04.004. Epub 2021 May 4.
5
Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后无复流现象的新预测因子及不良长期预后。
Indian Heart J. 2021 Jan-Feb;73(1):35-43. doi: 10.1016/j.ihj.2020.12.008. Epub 2020 Dec 29.
6
Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.ST段抬高型心肌梗死后高危患者的识别:血管造影参数与磁共振参数的比较
Circ Cardiovasc Imaging. 2017 Jun;10(6):e005841. doi: 10.1161/CIRCIMAGING.116.005841.
7
CHA2DS2-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention.CHA2DS2-VASc 评分预测多支血管病变行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者慢血流/无复流现象。
Medicine (Baltimore). 2021 May 28;100(21):e26162. doi: 10.1097/MD.0000000000026162.
8
Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,高岭土诱导的最大幅度与慢血流/无复流的关系。
Int J Cardiol. 2022 Dec 15;369:13-18. doi: 10.1016/j.ijcard.2022.08.025. Epub 2022 Aug 12.
9
The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.初始和残余血栓负荷对ST段抬高型心肌梗死患者无复流现象的影响。
Coron Artery Dis. 2015 May;26(3):245-53. doi: 10.1097/MCA.0000000000000197.
10
[A high-volume single center experience of no-reflow post-percutaneous coronary intervention].经皮冠状动脉介入术后无复流的高容量单中心经验
G Ital Cardiol (Rome). 2014 Feb;15(2):110-5. doi: 10.1714/1424.15780.

引用本文的文献

1
Identification and Management Strategies for Intracoronary High Thrombus Burden in Patients With STEMI: A Practical Experience and Literature Review.ST段抬高型心肌梗死患者冠状动脉内高血栓负荷的识别与管理策略:实践经验与文献综述
Rev Cardiovasc Med. 2025 Jul 30;26(7):37466. doi: 10.31083/RCM37466. eCollection 2025 Jul.
2
Molecular Mechanisms of Microvascular Obstruction and Dysfunction in Percutaneous Coronary Interventions: From Pathophysiology to Therapeutics-A Comprehensive Review.经皮冠状动脉介入治疗中微血管阻塞与功能障碍的分子机制:从病理生理学到治疗学——全面综述
Int J Mol Sci. 2025 Jul 16;26(14):6835. doi: 10.3390/ijms26146835.
3
Current and Future Roles of Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction.糖蛋白IIb-IIIa抑制剂在ST段抬高型心肌梗死直接血管成形术中的当前及未来作用
Biomedicines. 2024 Sep 4;12(9):2023. doi: 10.3390/biomedicines12092023.
4
Efficacy and Safety of Deferred Stenting in Geriatric Patients with STEMI and High Thrombus Burden.延迟支架置入术在老年ST段抬高型心肌梗死伴高血栓负荷患者中的疗效和安全性
Rev Cardiovasc Med. 2024 Mar 5;25(3):88. doi: 10.31083/j.rcm2503088. eCollection 2024 Mar.
5
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?超薄支柱药物洗脱支架相对于第二代和第三代药物洗脱支架有优势吗?
J Pers Med. 2023 Apr 28;13(5):753. doi: 10.3390/jpm13050753.

本文引用的文献

1
Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST Segment Resolution After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction With Initial Thrombolysis in Myocardial Infarction Grade 0.在初始心肌梗死溶栓分级为0级的ST段抬高型心肌梗死患者中,肾功能不全作为经皮冠状动脉介入治疗后慢血流/无复流现象及ST段回落受损的预测指标。
Circ J. 2021 Sep 24;85(10):1770-1778. doi: 10.1253/circj.CJ-21-0221. Epub 2021 Jul 20.
2
Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.接受直接经皮冠状动脉介入治疗患者无复流现象的临床、实验室及操作预测因素
J Tehran Heart Cent. 2020 Apr;15(2):50-56. doi: 10.18502/jthc.v15i2.4183.
3
Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流现象的预测
Medicine (Baltimore). 2020 Jun 26;99(26):e20152. doi: 10.1097/MD.0000000000020152.
4
Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention.入院时休克指数与急性心肌梗死患者行急诊经皮冠状动脉介入治疗后冠状动脉慢血流/无复流相关。
J Interv Cardiol. 2019 Jul 25;2019:7873468. doi: 10.1155/2019/7873468. eCollection 2019.
5
Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention.首次经皮冠状动脉介入治疗后无复流现象患者的临床和操作预测因素及其短期生存。
Int J Cardiol. 2019 Nov 1;294:27-31. doi: 10.1016/j.ijcard.2019.07.067. Epub 2019 Jul 23.
6
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.纤维蛋白原与白蛋白比值对预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流及短期预后的价值
Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16.
7
The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流现象的预测因素:一项荟萃分析。
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S406-S418. doi: 10.1016/j.ihj.2018.01.032. Epub 2018 Jan 31.
8
Pre-revascularization coronary wedge pressure as marker of adverse long-term left ventricular remodelling in patients with acute ST-segment elevation myocardial infarction.急性 ST 段抬高型心肌梗死患者冠状动脉楔压预血管成形术作为不良左心室重构的长期标志物。
Sci Rep. 2018 Jan 30;8(1):1897. doi: 10.1038/s41598-018-20276-6.
9
Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.平均血小板体积与淋巴细胞比值对预测ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后血管造影无复流及短期预后的价值
Am J Cardiol. 2017 Aug 15;120(4):534-541. doi: 10.1016/j.amjcard.2017.05.020. Epub 2017 May 30.
10
No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction.急性心肌梗死中冠状动脉内血栓导致的无复流现象
Chonnam Med J. 2016 Jan;52(1):38-44. doi: 10.4068/cmj.2016.52.1.38. Epub 2016 Jan 19.